Moderna (NASDAQ:MRNA) announced on Monday a new collaboration with an international health organization aimed at accelerating ...

Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support ...

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...

The MV Hondius outbreak has renewed focus on hantavirus vaccines, with Moderna developing an mRNA-based shot. The Andes strain's high mortality rate underscores the urgency for effective solutions.

Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Moderna gets up to $ 50 million to push forward an Ebola vaccine , as the outbreak seems to keep intensifying The biotech company Moderna has landed funding of as much as $50 million from CEPI , the ...

CEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This ...

Global health organization CEPI has committed roughly $60 million to accelerate the development of vaccines against the Ebola ...

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...

The vaccine was pioneered by S. Korea, while collaboration between Korea University & Moderna since 2023 has only been ...